Overview

iDAP Injection in the Treatment of Parkinson's Disease

Status:
NOT_YET_RECRUITING
Trial end date:
2028-10-01
Target enrollment:
Participant gender:
Summary
The goal of this clinical trial is to evaluate the safety, tolerability and preliminary efficacy that iDAP has on Parkinson's disease (PD) patients.
Phase:
EARLY_PHASE1
Details
Lead Sponsor:
Anhui Provincial Hospital